Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. Investigators in South Korea demonstrated the benefit in a ...
At University of Utah Health, our urologists have years of experience treating men with enlarged prostate issues — also known as benign prostatic hyperplasia (BPH). When other lines of treatment ...
TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback